INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 289 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,341 | +29.8% | 59,900 | +59.5% | 0.03% | +29.2% |
| Q1 2024 | $1,033 | -1.6% | 37,550 | +9.0% | 0.02% | -7.7% |
| Q4 2023 | $1,050 | -3.6% | 34,450 | 0.0% | 0.03% | -13.3% |
| Q3 2023 | $1,089 | -22.5% | 34,450 | 0.0% | 0.03% | -18.9% |
| Q2 2023 | $1,405 | +52.7% | 34,450 | +39.6% | 0.04% | +48.0% |
| Q1 2023 | $920 | – | 24,675 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |